Synthesis of methyl esters 21
Methyl 5-(N-benzyl-2-(N-benzyl-4-methylphenylsulfonamido)acetamido)-2-hydroxybenzoate (21a). To a solution of an amine 19a (0.100 g, 0.388 mmol) in CH 2 Cl 2 (2 ml) was added the acid 20e (0.130 g, 0.408 mmol) and coupling reagent Ph 3 PCl 2 (0.010 g, 0.932 mmol) under argon atmosphere. The resultant mixture was heated at 80 ºC in a microwave reactor (Biotage) for 1 h. The reaction was cooled to room temperature, diluted with CH 2 Cl 2 and washed with sat. NaHCO 3 . The organic fractions are dried (Na 2 SO 4 ) and evaporated in vacuo. The crude mixture was purified by column chromatography to afford the ester 21a (0.100 g, 0.179 mmol, 50%). 1 H NMR (400 MHz, CDCl 3 ) δ 10.76 (s, 1H), 7.82 (d, J = 8.3 Hz, 2H), 7.32 (d, J = 8.0 Hz, 2H), 7H), 2H), .00 (m, 2H), 6.73 (d, J = 8.8 Hz, 1H), 6.53 (dd, J = 8.8, 2.7 Hz, 1H) 
Methyl 5-(N-benzyl-2-(N-benzylbiphenyl-4-ylsulfonamido)acetamido)-2-hydroxybenzoate (21b). This was
obtained as a solid (0.108 g, 75%) from acid 20f (0.093 g, 0.244 mmol) and amine 19a (0.060 g, 0.233 mmol) in the same manner as described for 21a. 1 H NMR (400 MHz, CDCl 3 ) δ 10.77 (s, 1H), 8.00 (d, J = 10.4 Hz, 1H), 7.73 (d, J = 10.3 Hz, 1H), 1H), 7.49 (t, J = 7.4 Hz, 2H), 1H), 9H), 2H), 6.74 (d, J = 8.8 Hz, 1H), 6.55 (dd, J = 8.8, 2.7 Hz, 1H) 
Methyl

5-(2-(N-benzyl-4-methylphenylsulfonamido)-N-(4-chlorobenzyl)acetamido)-2-hydroxybenzoate
13
1H), 7H), 6.99 (d, J = 8.0 Hz, 2H), 6.94 (d, J = 8.1 Hz, 2H), 6.75 (d, J = 8.8 Hz, 1H), 6.57 (dd, J = 8.8, 2.6 Hz, 1H) 
Methyl 5-(N-benzyl-2-(N,4-dimethylphenylsulfonamido)acetamido)-2-hydroxybenzoate (21i).
This was obtained as a solid from acid 20f (0.083 g, 0.342 mmol) and amine 19a (0.084 g, 0.326 mmol) in the same manner as described for 21a and used immediately in the next step.
Methyl 5-(N-benzyl-2-(N-methylbiphenyl-4-ylsulfonamido)acetamido)-2-hydroxybenzoate (21j). This was
obtained as a solid (50-55%) from acid 20c (0.250 g, 0.818 mmol) and amine 19a (0.200 g, 0.778 mmol) in the same manner as described for 21a. 
Methyl 5-(N-(4-chlorobenzyl)-2-(N-methylbiphenyl-4-ylsulfonamido)acetamido)-2-hydroxybenzoate (21k).
This was obtained as a solid from acid 20c and amine 19d in the same manner as described for 21a and used immediately in the next step.
Methyl
5-(N-(4-cyclohexylbenzyl)-2-(N,4-dimethylphenylsulfonamido)acetamido)-2-hydroxybenzoate (21l).
This was obtained as a solid (40-45%) from acid 20a (0.075 g, 0.309 mmol) and amine 19b (0.100 g, 0.294 mmol) in the same manner as described for 21a. 1 
Methyl 5-(N-(4-cyclohexylbenzyl)-2-(N-methylbiphenyl-4-ylsulfonamido)acetamido)-2-hydroxy-benzoate (21m).
This was obtained as a solid (0.060 g, 0.096 mmol, 45%) from acid 20c (0.076 g, 0.248 mmol) and 19b
(0.080 g, 0.236 mmol) in the same manner as described for 21a. 1 H NMR (400 MHz, CDCl 3 ) δ 10.86 (s, 1H), 7.84 (d, J = 8.4 Hz, 2H), 7.69 (d, J = 8.5 Hz, 2H), 3H), 2H), 1H), 7.07 (d, J = 8.0 Hz, 2H), 3H), 6.94 (d, J = 8.8 Hz, 1H) 
5-(N-(4-Heptylbenzyl)-2-(N-methylbiphenyl-4-ylsulfonamido)acetamido)-2-hydroxybenzoic acid (21n).
This was obtained as a solid (0.088 g, 50%) from acid 20c (0.090 g, 0.294 mmol) and amine 19i (0.100 g, 0.282 mmol) in the same manner as described for 21a.5H), 6.93 (d, J = 8.8 Hz, 1H), 4.75 (s, 2H), 3.93 (s, 3H), 3.76 (s, 2H) 
Methyl
5-(2-(N-benzylbiphenyl-4-ylsulfonamido)-N-(4-(piperidin-1-yl)benzyl)acetamido)-2-hydroxybenzoate (21s).
This was obtained as a solid (0.113 g, 55%) from acid 20f (0.117 g, 0.308 mmol) and amine 19h (0.100 g, 0.294 mmol) in the same manner as described for 21a and was used in the next step without purification. 1 H NMR (400 MHz, CDCl 3 ) δ 10.78 (s, 1H), 8.01 (d, J = 8.5 Hz, 2H), 7.75 (d, J = 8.5 Hz, 2H), 3H), 2H), 6H), 2H), 6.74 (dd, J = 8.7, 1.7 Hz, 2H), 6.55 (dd, J = 8.8, 2.7 Hz, 1H) 
Methyl 5-(2-(N-benzylbiphenyl-4-ylsulfonamido)-N-(4-morpholinobenzyl)acetamido)-2-hydroxybenzoate (21u).
This was obtained as a solid (0.100 g, 60%) from acid 20f (0.117 g, 0.308) and amine 19e (0.100 g, 0.294 mmol) in the same manner as described for 21a. 1 H NMR (400 MHz, CDCl 3 ) δ 10.78 (s, 1H), 8.01 (d, J = 8.5 Hz, 2H), 7.75 (d, J = 8.5 Hz, 2H), 3H), 2H), 1H), 7H), 6.92 (d, J = 8.7 Hz, 2H), 6.77 (s, 1H), 6.71 (d, J = 8.7 Hz, 2H), 6.57 (dd, J = 8.9, 2.7 Hz, 1H), 4.64 (s, 3H), 3.93 (s, 4H), 7H), 3.66 (s, 2H), 7H) . 1H), 7.83 (d, J = 8.5 Hz, 2H), 7.69 (d, J = 8.5 Hz, 2H), 2H), 3H), , 1H 
Synthesis of carboxylic acids 11
General protocol: Methyl ester 21 (0.1 mmol) was dissolved in THF (2 ml) and 2M NaOH (excess) was added. The resulting biphasic mixture was refluxed overnight and then acidified to pH 2 with 4N HCl. The precipitated solids were collected by filtration and dried to afford the desired acids in 70-80% yields.
5-(N-Benzyl-2-(N-benzyl-4-methylphenylsulfonamido)acetamido)-2-hydroxybenzoic acid (11a).
A mixture of 21a (0.107 g, 0.107 mmol) in THF (2 mL) and sodium hydroxide (aq. 1 M, 2 mL) was refluxed overnight. This was obtained as a solid (0.050 g, mmol, 86%) from 21c (0.060 g, 0.101 mmol) in the same manner as described for 11a. 1 
5-(2-(N-Benzylbiphenyl-4-ylsulfonamido)-N-(4-chlorobenzyl)acetamido)-2-hydroxybenzoic acid (11d).
This was obtained as a solid (0.052 g, mmol, 88%) from 21d (0.060 g, 0.092 mmol) in the same manner as described for 11a. 1 
5-(2-(N-Benzylbiphenyl-4-ylsulfonamido)-N-(4-methoxybenzyl)acetamido)-2-hydroxybenzoic acid (11e).
This was obtained as a solid (0.054 g, 92%) from 21e (0.060 g, 0.092 mmol) in the same manner as described 
5-(2-(N-Benzylbiphenyl-4-ylsulfonamido)-N-(4-cyclohexylbenzyl)acetamido)-2-hydroxybenzoic acid (11f).
This was obtained as a solid (69%) from 21f (0.100 g) in the same manner as described for 11a. 
5-(2-(N-Benzylbiphenyl-4-ylsulfonamido)-N-(4-heptylbenzyl)acetamido)-2-hydroxybenzoic acid (11g).
This was obtained as a solid (0.058 g) from 21g in the same manner as described for 11a. 1 
5-(2-(N-Benzylbiphenyl-4-ylsulfonamido)-N-(4-isobutylbenzyl)acetamido)-2-hydroxybenzoic acid (11h).
This was obtained as a solid (0.050 g) from 21h in the same manner as described for 11a. 1 
5-(N-Benzyl-2-(N,4-dimethylphenylsulfonamido)acetamido)-2-hydroxybenzoic acid (11i).
This was obtained as a solid (0.030g, 78%) from 21i (0.040 g, 0.083 mmol) in the same manner as described for 11a. 
5-(N-Benzyl-2-(N-methylbiphenyl-4-ylsulfonamido)acetamido)-2-hydroxybenzoic acid (11j
5-(N-(4-Chlorobenzyl)-2-(N-methylbiphenyl-4-ylsulfonamido)acetamido)-2-hydroxybenzoic acid (11k).
This was obtained as a solid from 21k (0.060 g, 0.104 mmol) in the same manner as described for 11a. 1 
5-(N-(4-Cyclohexylbenzyl)-2-(N,4-dimethylphenylsulfonamido)acetamido)-2-hydroxybenzoic acid (11l).
This was obtained as a solid (80%) from 21l (0.030 g, 0.053 mmol) in the same manner as described for 11a. 
5-(N-(4-Cyclohexylbenzyl)-2-(N-methylbiphenyl-4-ylsulfonamido)acetamido)-2-hydroxybenzoic acid (11m).
This was obtained as a solid from 21m (0.045 g, 0.0719 mmol) in the same manner as described for 
5-(N-(4-Heptylbenzyl)-2-(N-methylbiphenyl-4-ylsulfonamido)acetamido)-2-hydroxybenzoic acid (11n).
This was obtained as a solid from 21n (0.050 g) in the same manner as described for 11a. 1 
5-(2-(4'-Chloro-N-methylbiphenyl-4-ylsulfonamido)-N-(4-chlorobenzyl)acetamido)-2-hydroxybenzoic acid (11p).
This was obtained as a solid (0.043 g, 73%) from 21p (0.060 g, 0.98 mmol) in the same manner as described for 11a. 1 
5-(2-(4'-Chloro-N-methylbiphenyl-4-ylsulfonamido)-N-(4-methoxybenzyl)acetamido)-2-hydroxybenzoic acid (11q).
This was obtained as a solid (0.035 g, 60%) from 21q (0.060 g, 0.099 mmol) in the same manner as 
5-(2-(4'-Fluoro-N-methylbiphenyl-4-ylsulfonamido)-N-(4-heptylbenzyl)acetamido)-2-hydroxybenzoic acid (11r).
This was obtained as a solid from 21r (0.080 g) in the same manner as described for 11a. 1 
5-(2-(N-Benzylbiphenyl-4-ylsulfonamido)-N-(4-(piperidin-1-yl)benzyl)acetamido)-2-hydroxybenzoic acid (11s).
This was obtained as a solid (0.050 g) from 21s in the same manner as described for 11a. 1 
5-(2-(N-Benzylbiphenyl-4-ylsulfonamido)-N-(4-morpholinobenzyl)acetamido)-2-hydroxybenzoic acid (11u).
This was obtained as a solid (0.056 g) from 21u in the same manner as described for 11a. 1 
2-Hydroxy-5-(2-(N-methylbiphenyl-4-ylsulfonamido)-N-(4-(piperidin-1-yl)benzyl)acetamido)benzoic acid (11v).
This was obtained as a solid from 21v (0.050 g) in the same manner as described for 11a. 1 
Synthesis of diethyl phosphonylanilines 25
Scheme S1. Synthesis of the phosphonate-containing anilines 25a, 25b and 25d.
Diethyl 4-nitrophenylphosphonate. 4 1-bromo-4-nitrobenzene (2.02 g, 10 mmol) was suspended in EtOH (10 ml) and THF (5 ml) was added to afford a homogeneous solution. The solution was degassed, a vacuum applied to the flask, which was then filled with argon. This process was repeated 3 times. The catalyst Pd(Ph 3 P) 4 (0.578 g, 0.5 mmol) was added under argon atmosphere and the mixture was again degassed, a vacuum applied to the flask which was then refilled with argon. Triethylamine (2.8 ml, 20 mmol) and diethyl phosphite (1.93 ml, 15 mmol) were added via syringe. The resulting solution was refluxed for 24 h under argon and cooled to room temperature. The insoluble material was filtered and the filtrate concentrated to provide the crude product which was dissolved in EtOAc (50 ml) and filtered. The residue was washed with EtOAc (2 × 25 ml 
Diethyl 3-aminobenzylphosphonate (25d).
4 Diethyl 3-nitrobenzylphosphonate (1.366 g, 5.00 mmol) was dissolved in THF (5 ml). The solution was hydrogenated with Pd/C (10%, 0.100 g) catalyst under H 2 atmosphere at room temperature overnight. The catalyst was filtered off through a pad of celite and washed with THF (2 × 5 ml). The filtrate was concentrated to dryness affording the aniline 25c (1.300 g, 100%) as yellow oil which was used without further purification.
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Synthesis of diethyl phosphonates 26
Diethyl 4-(4-phenoxybenzamido)phenylphosphonate (26a). This compound was synthesized according to the procedure used to prepare 26c using 4-phenoxybenzoic acid (0.214 g, 1 mmol), 25a (0.229 g, 1 mmol), EDC (0.211 g, 1.1 mmol) and DMAP (0.012g, 0.1 mmol) in DCM (5 ml). The reaction mixture was concentrated and the residue suspended in EtOAc (50 ml) and washed with HCl (1 N, 3 × 10 ml), water (2 × 10 ml) and brine (10 ml 
Benzyl bromide 27
Methyl 4-cyclohexylbenzoate. 18.28 mmol) in MeOH (35 mL) was refluxed under Argon for 40 h in presence of H 2 SO 4 (conc., 0.40 mL). The reaction mixture was concentrated and NaHCO 3 (aq., sat., 100 ml) added to the residue. The mixture was extracted with EtOAc (2 × 100 mL). 
1-(Bromomethyl)-4-cyclohexylbenzene (17)
. 6 Supported triphenylphosphine PS-Ph 3 P (1 g, 2 mmol) was added to (4-cyclohexylphenyl)methanol (0.190 g, 1 mmol) in DCM (10 ml 
Diethyl 4-(N-(4-cyclohexylbenzyl)-4-phenoxybenzamido)phenylphosphonate (28a). This compound was
prepared, according to the procedure used to make 28d, from 26a (0.115 g, 0.27 mmol), NaH (0.011 g, 0.27 mmol), 27 (0.076 g, 0.3 mmol) affording the title compound 28a (0.041 g, 25%) as a colorless oil and the starting 26a (0.041 g, 36%) was recovered. 4H), 7.20 (d, J = 7.9 Hz, 2H), 3H), 7.04 (dd, J = 8.1, 3.5 Hz, 2H), 
3-(N-(4-cyclohexylbenzyl)-4-phenoxybenzamido)phenylphosphonic acid (12b).
This was prepared from the amide 28b (0.119 g, 0.199 mmol) in a similar manner as described for 29b. The obtained crude material was slurried with hexane/EtOAc (9/1, 1 ml), filtered, washed with hexane (1 mL), dried under vacuum to afford 12b
as an off-white solid (0.059 g, 0.108 mmol, 55% 
4-(N-(4-Cyclohexylbenzyl)-4-phenoxybenzamido)benzylphosphonic acid (12c)
. TMSBr (0.216 ml, 1.63 mmol) was added to a solution of 28c (0.100 g, 0.163 mmol) in DCM (3 ml) at 0 °C. The mixture was stirred at room temperature for 4 h and concentrated. The residue was stirred with 90% CH 3 OH/H 2 O (10 ml) at room temperature for 1 h and concentrated. The crude product was slurried in acetone (2 ml) and filtered. The solid was washed with acetone (2 × 1 ml) and dried affording the title compound 12c (0.046 g, 51%) as an off-white solid. m.p. 188 ºC (dec.). 1 H NMR (400 MHz, 4H), 7H), 6.96 (t, J = 8.6 Hz, 4H), 6.75 (d, J = 8.7 Hz, 2H), 5.08 (s, 2H), 3.03 (d, J = 21.7 Hz, 2H), 1H) 
3-(N-(4-Cyclohexylbenzyl)-4-phenoxybenzamido)benzylphosphonic acid (12d).
This compound was prepared, according to the procedure used to make 12c, from 28d (0.109 g, 0.18 mmol) and bromotrimethylsilane (0.24 ml, 1.78 mmol) in DCM (5 ml 4H), 7.20 (d, J = 8.1 Hz, 3H), 4H), 7.07 (t, J = 7.6 Hz, 1H), 6.94 (d, J = 7.9 Hz, 2H), 6.75 (d, J = 8.5 Hz, 2H), 6.68 (d, J = 7.4 Hz, 1H) 3-(4-Phenoxybenzamido)phenylphosphonic acid (29b). Bromotrimethylsilane (0.464 g, 3.03 mmol) was added dropwise under argon to a solution of 26b (0.137 g, 0.322 mmol) in anhydrous DCM (0.5 mL). After stirring at room temperature overnight, the solvent and excess of TMS-Br were removed under reduced pressure. A mixture of MeOH/water (9/1, 2 mL) was added and the reaction mixture was stirred at room temperature for 1 h. The solvent was removed under reduced pressure to provide an orange oil. Water (10 mL) was added and the solid that precipitated was filtered, washed with water (5 mL) and dried under vacuum to afford pure 29b as an off-white solid (0.096 g, 81% 1 Hz, 1H), 7.95 (d, J = 8.7 Hz, 2H), 7.91 (d, J = 7.8 Hz, 1H), 1H), 1H), 7.42 (t, J = 7.9 Hz, 2H), 7.21 (t, J = 7.4 Hz, 1H), 7.08 (d, J = 8.1 Hz, 2H), 7.05 (d, J = 8.7 Hz, 2H) 
2-Hydroxy-5-(N-(4-methoxybenzyl)-4-phenoxybenzamido)benzoic acid (13b). This was prepared from 30b
(0.097 g, 0.200 mmol) in the same manner as described for 13g. The crude product was slurried with methanol (1 mL), filtered and dried under vacuum to afford pure 13b as a white solid (0.035 g, 0.074 mmol, 37%). m.p. 
2-Hydroxy-5-(N-(3,4-dimethoxybenzyl)-4-phenoxybenzamido)benzoic acid (13c).
A mixture of 30c (0.081 g, 0.157 mmol) in THF (1 mL) and sodium hydroxide (aq. 1 M, 1 mL) was heated at 70 ºC in a sealed tube overnight. The solvent was then removed under reduced pressure. Hydrochloric acid (aq. 1 M, 2 mL) was added to the mixture which was then extracted with EtOAc (2 × 5 mL). The organic extracts were combined, dried (Na 2 SO 4 ), filtered and the solvent removed under reduced pressure to provide 13c as a white solid (0.053 g, 0.106 mmol, 68%).
The obtained solid was slurried in citric acid (aq. sat., 10 mL), filtered, water (2 × 5 mL) × 100. Polarization values were calculated according to the equation mP = 1000 ×(S -G×P)/(S + G×P) where S is the value from the S channel, P the value from the P channel and G the G-factor). GraphPad was employed to determine the IC 50 using nonlinear curve fitting (see Figure S1 for the IC 50 of 13g).
Figure S1: Dose-response of 13g (IC 50 12 µM).
Molecular modeling
GLIDE (Schrödinger, Inc.) was used to the phosphonic acid 12d and salicylic acids 13f and 13g to the ApY*LK model of the binding site of the STAT3 SH2 domain based on the X-ray crystal structure of the STAT3 dimer bound to DNA. 10 The docking methods are described in detail elsewhere. 7 PyMol (Schrodinger, Inc.) was used to produce the Figures 2, S2 and S3.
Effects of selected compounds upon pSTAT3 levels in MDA-MB-468 human breast cancer cells
The Western blot experiments were performed as described by us previously. 
